{"record": {"aliases": [], "artifacts": [{"id": "arxiv:2607.25518", "kind": "paper", "url": "https://arxiv.org/abs/2607.25518"}, {"id": "hf:zihengzhou06/ampbench-mt", "kind": "dataset", "url": "https://huggingface.co/datasets/ZihengZhou06/AMPBench-MT"}], "authors": ["Ziheng Zhou", "Huiyu Luo", "Xiaohu Zhu", "Nan Wang", "Xuebiao Qin", "Chaoyan Zhang", "Jun Yan"], "authors_reference": {"basis": "arxiv_metadata", "retrieved_at": "2026-11-03", "source_key": "claire-radar:2607.25518", "source_url": "https://arxiv.org/abs/2607.25518"}, "categories": ["Biology & Drug Discovery", "Safety", "Safety & Trustworthiness"], "description": {"en": "AMPBench-MT evaluates antimicrobial peptide prediction across binary recognition, species-conditioned potency regression, and endpoint-specific safety readouts (hemolysis, toxicity, selectivity) under a sequence-homology-controlled protocol. It includes 13 source databases and multiple task configurations."}, "documents": [{"document_type": "registry_page", "id": "claire_radar:https://arxiv.org/abs/2607.25518", "source": "claire_radar", "source_url": "https://arxiv.org/abs/2607.25518", "title": "AMPBench-MT"}], "evidence_summary": {"document_count": 1, "model_count": null, "model_count_basis": null}, "institutions": ["Shanghai Ocean University", "Tongji University"], "institutions_reference": {"basis": "openalex_linked_institutions", "doi": "10.48550/arxiv.2607.25518", "retrieved_at": "2026-11-04", "source_key": "claire-radar:2607.25518", "source_url": "https://openalex.org/W7171700595"}, "key": "claire-radar:2607.25518", "modality": null, "name": "AMPBench-MT", "openness": {"code_license": null, "data_license": null, "evidence": [], "status": "unknown"}, "provenance": {"confidence": "High", "crawl_bundle": "claire_radar_2026-10-14", "crawled_at": "2026-10-14T09:44:51Z", "data_status": "primary-source-indexed", "display_eligible": "unknown", "origin_record_id": "bm_ampbench-mt_ce75d23c", "origin_source": "arxiv", "recognition_confidence": "1.0", "record_sha256": "a128259f1f32024eed45b8856659e5d9e3a8e4522dd65ecfd8df1fbb0c6d6fe8", "relation": "introduces", "review_state": "unreviewed", "source_url": "https://arxiv.org/abs/2607.25518"}, "publisher": null, "released": "2026-07-28", "released_reference": {"basis": "benchmark_release", "source_key": "claire-radar:2607.25518", "source_url": "https://arxiv.org/abs/2607.25518"}, "schema_version": 1, "sizes": [], "slug": "claire-radar-2607-25518", "source": "claire_radar", "source_benchmark_id": "2607.25518", "source_metadata": {"claire_radar": {"adoption30d": null, "aliases": [], "annotation": "Unknown", "applicationDomains": ["Biology & Drug Discovery"], "area": "Safety & Trustworthiness", "attention": {"asOf": "2026-10-05", "attemptedAt": "2026-10-04T15:31:48.030916Z", "githubRepo": null, "githubScope": null, "githubStars": null, "hfDailySubmittedAt": null, "hfDataset": "ZihengZhou06/AMPBench-MT", "hfDatasetDownloads": 311, "hfDatasetLikes": 0, "hfPaperUpvotes": null, "hfPaperUrl": "https://huggingface.co/papers/2607.25518", "observedAt": "2026-10-04T15:31:48.030916Z", "signalStatus": {"githubStars": {"state": "not_applicable"}, "hfDatasetDownloads": {"observedAt": "2026-10-04T15:31:48.030916Z", "state": "fresh"}, "hfDatasetLikes": {"observedAt": "2026-10-04T15:31:48.030916Z", "state": "fresh"}, "hfPaperUpvotes": {"checkedAt": "2026-10-04T15:31:48.030916Z", "state": "unavailable"}}, "status": "fresh"}, "capabilities": [], "confidence": "High", "construction": "Unknown", "constructionDetail": "Unknown — the indexer does not infer construction details without explicit source evidence.", "copyGeneration": {"generatedAt": "2026-08-20T15:22:10.044731Z", "inputHash": "07fd4dc06b2bb0d6870849797c961b38c190b015b407d037f771ad32e82f1e03", "model": "deepseek-v4-flash"}, "dataStatus": "primary-source-indexed", "demo": false, "description": "AMPBench-MT evaluates antimicrobial peptide prediction across binary recognition, species-conditioned potency regression, and endpoint-specific safety readouts (hemolysis, toxicity, selectivity) under a sequence-homology-controlled protocol. It includes 13 source databases and multiple task configurations.", "domainCuration": {"method": "rules-v1", "state": "auto"}, "evidence": {"reasonCodes": ["exact coined title identity tied to benchmark evidence", "benchmark release stated in one sentence", "evaluation protocol evidence", "public artifact URL"], "snippet": "To address this problem, we introduce AMPBench-MT, a provenance-preserving benchmark that standardizes canonical peptide records and organizes them into binary recognition, species-conditioned pMIC regression, and endpoint-specific potency and safety-facing readouts."}, "familyId": "bmf_d0c8104c4688", "firstSeenAt": "2026-08-19", "githubIndex": {"candidateCount": 3, "indexedAt": "2026-09-17T04:40:34.111665+00:00", "repositories": [], "status": "candidates"}, "heat": null, "id": "bm_ampbench-mt_ce75d23c", "indexedAt": "2026-08-19T11:05:13.395391Z", "industrySectors": ["Pharma & Biotech"], "links": {"code": null, "data": "https://huggingface.co/datasets/ZihengZhou06/AMPBench-MT", "hfPaper": "https://huggingface.co/papers/2607.25518", "paper": "https://arxiv.org/abs/2607.25518", "pdf": "https://arxiv.org/pdf/2607.25518", "project": null, "report": "https://arxiv.org/abs/2607.25518"}, "metrics": [], "motivation": "Computational AMP discovery is often evaluated through AMP/non-AMP recognition, yet follow-up decisions depend on assay-derived evidence such as target-species potency, hemolysis, toxicity, and selectivity.", "name": "AMPBench-MT", "oneLine": "AMPBench-MT evaluates antimicrobial peptide prediction across binary recognition, species-conditioned potency regression, and endpoint-specific safety readouts (hemolysis, toxicity, selectivity) under a sequence-homology-controlled protocol. It includes 13 source databases and multiple task configurations.", "paperTitle": "AMPBench-MT: A Homology-Controlled Benchmark for Antimicrobial Peptide Potency, Spectrum, and Safety Prediction", "primaryDomain": "Biology & Drug Discovery", "publication": {"evidence": null, "evidenceLevel": "unverified", "evidenceUrl": "https://arxiv.org/abs/2607.25518", "source": "arxiv-metadata", "status": "unverified", "venue": null, "verifiedAt": "2026-10-14T01:46:58.058199Z"}, "publications": [], "publishers": [{"name": "ZihengZhou06", "organizationType": "community", "role": "benchmark-publisher", "sourceUrl": "https://huggingface.co/datasets/ZihengZhou06/AMPBench-MT"}], "ranking": {"90d": {"confidence": "Low", "coverage": 0.3, "datasetDownloadRank": 36, "datasetRankPopulation": 85, "growth": {"components": {"githubStars": {"normalization": "percentile", "normalized": null, "percentile": null, "value": null}, "hfDatasetDownloads": {"normalization": "percentile", "normalized": null, "percentile": null, "value": null}, "hfPaperUpvotes": {"normalization": "percentile", "normalized": null, "percentile": null, "value": null}}, "confidence": "Low", "coverage": 0.0, "elapsedDays": null, "historyDate": null, "rank": null, "score": null, "windowDays": 90}, "level": {"components": {"githubStars": {"normalization": "log-max", "normalized": null, "value": null}, "hfDatasetDownloads": {"normalization": "log-max", "normalized": 0.5914140254000603, "value": 311}, "hfPaperUpvotes": {"normalization": "log-max", "normalized": null, "value": null}}, "confidence": "Low", "coverage": 0.3, "rank": 42, "score": 53}, "method": "attention-ranking-v13", "rank": 42, "score": 53}}, "readiness": "Inspectable", "recognitionConfidence": 1.0, "relation": "introduces", "releasedAt": "2026-07-28", "source": {"authors": ["Ziheng Zhou", "Huiyu Luo", "Xiaohu Zhu", "Nan Wang", "Xuebiao Qin", "Chaoyan Zhang", "and Jun Yan"], "categories": ["cs.LG", "q-bio.QM"], "id": "2607.25518", "title": "AMPBench-MT: A Homology-Controlled Benchmark for Antimicrobial Peptide Potency, Spectrum, and Safety Prediction", "type": "arxiv", "url": "https://arxiv.org/abs/2607.25518"}, "sourceUpdatedAt": "2026-07-28T10:01:30Z", "topics": ["Safety"], "venueAttempts": [], "whyItMatters": "Existing AMP benchmarks focus on binary recognition, but follow-up decisions need assay-derived evidence. AMPBench-MT provides a joint evaluation with homology-controlled splits to reveal that high binary performance does not guarantee assay-endpoint behavior."}}}, "schema_version": 1, "scores_by_source": {}, "siblings": []}
